Albert Altés
YOU?
Author Swipe
View article: Immunoparesis Recovery in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients, an Independent Prognostic Factor That Complements Minimal Residual Disease
Immunoparesis Recovery in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients, an Independent Prognostic Factor That Complements Minimal Residual Disease Open
Information on the prognostic value of immunoparesis (IP) recovery in multiple myeloma (MM) patients has been only generated in some observational and retrospective studies. We have evaluated the prognostic impact of IP recovery and its as…
View article: Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice
Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice Open
Acute myeloid leukemia has a poor prognosis in older adults, and its management is often unclear due to its underrepresentation in clinical trials. Both overall survival (OS) and health-related quality-of-life (HRQoL) are key outcomes in t…
View article: Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes Open
Purpose: Irinotecan is an important drug for the treatment of solid tumors. Although genes involved in irinotecan pharmacokinetics have been shown to influence toxicity, there are no data on pharmacodynamic genes. CDC45L, NFKB1, PARP1, TDP…
View article: Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes Open
Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
View article: Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes Open
Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
View article: Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes Open
Purpose: Irinotecan is an important drug for the treatment of solid tumors. Although genes involved in irinotecan pharmacokinetics have been shown to influence toxicity, there are no data on pharmacodynamic genes. CDC45L, NFKB1, PARP1, TDP…
View article: Validation of MRI‐VLFF for the non‐invasive measurement of steatosis in children
Validation of MRI‐VLFF for the non‐invasive measurement of steatosis in children Open
Background & Aims: Magnetic resonance-based steatosis measurement of the liver has become the non-invasive gold standard; however very few diagnostic thresholds have been independently validated and none in children. This study was designe…
View article: Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys Open
ClinicalTrials.gov Identifier: NCT02513121.